APA

Wolff H. A., Wolff C. R. M., Hess C. F., Jung K., Sennhenn-Kirchner S., Hinterthaner M., Müller-Dornieden A., Körber W., Marten-Engelke K., Roedel R., Christiansen H. & Engelke C. (20140106). Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Chicago

Wolff H A, Wolff C R M, Hess C F, Jung K, Sennhenn-Kirchner S, Hinterthaner M, Müller-Dornieden A, Körber W, Marten-Engelke K, Roedel R, Christiansen H and Engelke C. 20140106. Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Harvard

Wolff H. A., Wolff C. R. M., Hess C. F., Jung K., Sennhenn-Kirchner S., Hinterthaner M., Müller-Dornieden A., Körber W., Marten-Engelke K., Roedel R., Christiansen H. and Engelke C. (20140106). Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

MLA

Wolff H A, Wolff C R M, Hess C F, Jung K, Sennhenn-Kirchner S, Hinterthaner M, Müller-Dornieden A, Körber W, Marten-Engelke K, Roedel R, Christiansen H and Engelke C. Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease. : Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 20140106.